Indo Borax completes 64.26% Kronox stake buy, names new MD & CEO at subsidiary
INDOBORAX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 1.4 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indo Borax & Chemicals completed acquisition of 64.26% stake in Kronox Lab Sciences on Sept 29, with former promoters keeping 9.95%. As part of integration, Suresh Kalra was appointed MD and CEO of Kronox for 5 years, bringing 25 plus years in chemicals. Shashikant Bharuka was named CFO. A new board of 3 executive and 3 independent directors was constituted, with audit and other committees reconstituted. Kronox reported FY26 revenue of about INR 101 crore and PAT of about INR 28 crore.
Major acquisition adds specialty chemicals revenue and diversifies Indo Borax's portfolio. New leadership signals an operational integration push at Kronox.